STAT5A, STAT5B, STAT6 proteins as a molecular target in the treatment of basal cell carcinoma

摘要

The subject of the notification is STAT5A, STAT5B protein, STAT6 and its potential use as a molecular objective for existing or new anti-STAT medicines used locally (on the skin) or in combination for the treatment of basal cell skin cancer, alternatively for surgical treatment or as a supplementary surgical method.